Results from clinical trials with BELEODAQ1

BELEODAQ was evaluated in a clinical study that included 129 patients for whom other PTCL treatments were no longer working. The study included patients who had the most common types of PTCL.

Response Rate

The clinical study also showed that BELEODAQ delivered a measurable response in the two most common types of PTCL: PTCL-NOS and AITL.

Overall response Rate

Complete response rate2
The percentage of patients who have the disappearance of all signs of cancer in response to treatment. This does not always mean the cancer has been cured. Also called complete remission.

Partial response rate2
The percentage of patients who have a decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment. Also called partial remission.

Overall response rate2
The percentage of patients whose cancer shrinks after treatment and includes patients who have a complete and partial response. Complete response + partial response = overall response rate.